# Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation

> **NCT01853358** · PHASE1 · COMPLETED · sponsor: **Institut Paoli-Calmettes** · enrollment: 17 (estimated)

## Conditions studied

- Hematological Malignancy

## Interventions

- **BIOLOGICAL:** NK Cell infusion

## Key facts

- **NCT ID:** NCT01853358
- **Lead sponsor:** Institut Paoli-Calmettes
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2018-03-15
- **Final completion:** 2018-03-15
- **Target enrollment:** 17 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01853358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01853358, "Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01853358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*